BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Xie X, Hu Y, Ye T, Chen Y, Zhou L, Li F, Xi X, Wang S, He Y, Gao X, Wei W, Ma G, Li Y. Therapeutic vaccination against leukaemia via the sustained release of co-encapsulated anti-PD-1 and a leukaemia-associated antigen. Nat Biomed Eng 2021;5:414-28. [PMID: 33046865 DOI: 10.1038/s41551-020-00624-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Wang D, Gu W, Chen W, Zhou J, Yu L, Kook Kim B, Zhang X, Seung Kim J. Advanced nanovaccines based on engineering nanomaterials for accurately enhanced cancer immunotherapy. Coordination Chemistry Reviews 2022;472:214788. [DOI: 10.1016/j.ccr.2022.214788] [Reference Citation Analysis]
2 Li X, Zhang Y, Wu X, Chen J, Yang M, Ma F, Shi L. In Situ Antigen-Capturing Nanochaperone Toward Personalized Nanovaccine for Cancer Immunotherapy. Small 2022;:e2203100. [PMID: 35843873 DOI: 10.1002/smll.202203100] [Reference Citation Analysis]
3 Levalley PJ, Parsons AL, Sutherland BP, Kiick KL, Oakey JS, Kloxin AM. Microgels Formed by Spontaneous Click Chemistries Utilizing Microfluidic Flow Focusing for Cargo Release in Response to Endogenous or Exogenous Stimuli. Pharmaceutics 2022;14:1062. [DOI: 10.3390/pharmaceutics14051062] [Reference Citation Analysis]
4 Ruan S, Huang Y, He M, Gao H. Advanced Biomaterials for Cell-Specific Modulation and Restore of Cancer Immunotherapy. Adv Sci (Weinh) 2022;9:e2200027. [PMID: 35343112 DOI: 10.1002/advs.202200027] [Reference Citation Analysis]
5 Bai Y, Wang T, Zhang S, Chen X, He C. Recent advances in organic and polymeric carriers for local tumor chemo-immunotherapy. Sci China Technol Sci . [DOI: 10.1007/s11431-021-1961-y] [Reference Citation Analysis]
6 Wang W, Zhao J, Hao C, Hu S, Chen C, Cao Y, Xu Z, Guo J, Xu L, Sun M, Xu C, Kuang H. The Development of Chiral Nanoparticles to Target NK Cells and CD8+ T Cells for Cancer Immunotherapy. Adv Mater 2022;34:e2109354. [PMID: 35176181 DOI: 10.1002/adma.202109354] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
7 Ci T, Zhang W, Qiao Y, Li H, Zang J, Li H, Feng N, Gu Z. Delivery strategies in treatments of leukemia. Chem Soc Rev 2022. [PMID: 35188506 DOI: 10.1039/d1cs00755f] [Reference Citation Analysis]
8 Liu J, Liew SS, Wang J, Pu K. Bioinspired and Biomimetic Delivery Platforms for Cancer Vaccines. Adv Mater 2022;34:e2103790. [PMID: 34651344 DOI: 10.1002/adma.202103790] [Cited by in Crossref: 10] [Cited by in F6Publishing: 18] [Article Influence: 10.0] [Reference Citation Analysis]
9 Du J, Liu X, Yarema KJ, Jia X. Glycoengineering human neural stem cells (hNSCs) for adhesion improvement using a novel thiol-modified N-acetylmannosamine (ManNAc) analog. Materials Science and Engineering: C 2022. [DOI: 10.1016/j.msec.2022.112675] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Zhang Y, An J, Shao Y, Yu N, Yue S, Sun H, Zhang J, Gu W, Xia Y, Zhang J, Xu Y, Zhong Z. CD38-Directed Vincristine Nanotherapy for Acute Lymphoblastic Leukemia. Biomacromolecules 2021. [PMID: 34913676 DOI: 10.1021/acs.biomac.1c01342] [Reference Citation Analysis]
11 Christensen RL, Hendel KK, Persson DP, Husted S, Olesen UH, Haedersdal M. Topical delivery of PD-1 inhibitors with laser-assisted passive diffusion and active intradermal injection: Investigation of cutaneous pharmacokinetics and biodistribution patterns. Lasers Surg Med 2021. [PMID: 34859463 DOI: 10.1002/lsm.23504] [Reference Citation Analysis]
12 Gu W, Qu R, Meng F, Cornelissen JJLM, Zhong Z. Polymeric nanomedicines targeting hematological malignancies. J Control Release 2021;337:571-88. [PMID: 34364920 DOI: 10.1016/j.jconrel.2021.08.001] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
13 Zhang L, Zhang J, Xu L, Zhuang Z, Liu J, Liu S, Wu Y, Gong A, Zhang M, Du F. NIR responsive tumor vaccine in situ for photothermal ablation and chemotherapy to trigger robust antitumor immune responses. J Nanobiotechnology 2021;19:142. [PMID: 34001148 DOI: 10.1186/s12951-021-00880-x] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
14 Liang J, Zhao X. Nanomaterial-based delivery vehicles for therapeutic cancer vaccine development. Cancer Biol Med 2021:j. [PMID: 33979069 DOI: 10.20892/j.issn.2095-3941.2021.0004] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
15 Chen J, Zhang H, Zhou L, Hu Y, Li M, He Y, Li Y. Enhancing the Efficacy of Tumor Vaccines Based on Immune Evasion Mechanisms. Front Oncol 2020;10:584367. [PMID: 33614478 DOI: 10.3389/fonc.2020.584367] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
16 Jiang H, Hu X, Li Y, Ngai T. A green and facile strategy for the fabrication of all-natural porous proteinaceous microspheres. Mater Chem Front 2021;5:3897-902. [DOI: 10.1039/d0qm01010c] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
17 Liu Y, Li N, Zhu X, Qi Y. How wide is the application of genetic big data in biomedicine. Biomed Pharmacother 2021;133:111074. [PMID: 33378973 DOI: 10.1016/j.biopha.2020.111074] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]